Literature DB >> 1146998

Plasma K plus and insulin: changes during KCl infusion in normal and nephrectomized dogs.

G W Pettit, R L Vick, A M Swander.   

Abstract

Potassium chloride was administered by constant, intravenous infusion in splenectomized, but otherwise normal, dogs. The concentration of potassium, [K+], and of insulin, [insulin], in the arterial plasma was measured at frequent intervals. To assess the relative contributions of extrarenal and renal mechanisms toward the maintenance of normal plasma [K+], the results were compared with data obtained previously in splenectomized, nephrectomized dogs. During the infusion, plasma [K+] increased in the dogs with kidneys intact at a mean rate slightly less than that in the nephrectomized dogs. After the infusion was stopped, plasma [K+] declined to about 0.75 meq/liter above control values in both groups of animals. The results indicate the operation of both renal and extrarenal homoeostatic mechanisms. The renal mechanisms contributed measurably during the infusion of KCl, but not immediately after the infusion was stopped. Simultaneous measurements of plasma [K+] and plasma [insulin] indicate that insulin may be involved in the extrarenal homeostatic response.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1146998     DOI: 10.1152/ajplegacy.1975.228.1.107

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

1.  Control of plasma aldosterone in diabetic patients with hyporeninemic hypoaldosteronism.

Authors:  U Kuhlmann; W Vetter; E Fischer; W Siegenthaler
Journal:  Klin Wochenschr       Date:  1978-03-01

2.  Effects of standard oral glucose loading on the renin-angiotensin-aldosterone system and its relationship to circulating insulin.

Authors:  C Beretta-Piccoli; P Weidmann; J Flammer; Z Glück; C Bachmann
Journal:  Klin Wochenschr       Date:  1980-05-02

3.  Influence of basal insulin and glucagon secretion on potassium and sodium metabolism. Studies with somatostatin in normal dogs and in normal and diabetic human beings.

Authors:  R A DeFronzo; R S Sherwin; M Dillingham; R Hendler; W V Tamborlane; P Felig
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.